Wataru Anno

Japanese Foundation For Cancer Research

Papers

1

Total Citations

6

H-Index

1

About

Wataru Anno is a leading researcher in radiation oncology, with a primary focus on advanced treatment planning for prostate cancer. His work centers on optimizing ultrahypofractionated radiation therapy, comparing the efficacy and dosimetry of high-dose-rate brachytherapy (HDR-BT) against robotic and conventional stereotactic body radiotherapy (SBRT). His most cited paper (2023, 6 citations) provides a critical treatment planning comparison for these modalities, offering valuable insights into their clinical trade-offs. Anno’s contributions help refine personalized cancer care by evaluating dose distribution, organ-at-risk sparing, and treatment precision. Though early in his citation impact, his research addresses a rapidly evolving area in oncology, bridging technological innovation with practical clinical application. His work is particularly notable for its direct relevance to improving outcomes in ultrahypofractionated prostate cancer treatment, a field gaining momentum worldwide.

Research Focus

Key Achievements

1
H-Index
1
Papers
6
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Treatment planning comparison of high-dose-rate brachytherapy vs. robotic and conventional stereotactic body radiotherapy for ultrahypofractionated treatment of prostate cancer
6 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Japanese Foundation For Cancer Research

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago